Cite
HARVARD Citation
Grossmann, P. et al. (2017). Quantitative imaging biomarkers for risk stratification of patients with recurrent glioblastoma treated with bevacizumab. Neuro-oncology. 19 (12), pp. 1688-1697. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Grossmann, P. et al. (2017). Quantitative imaging biomarkers for risk stratification of patients with recurrent glioblastoma treated with bevacizumab. Neuro-oncology. 19 (12), pp. 1688-1697. [Online].